Declaration of Conduct and ISO26000 Core Subjects
Sumitomo Pharma believes it is important to correctly identify those risks that will impact our business activities as well as the ways in which our business may impact society and the environment and to respond to these risks and impacts appropriately. As such, we have established our Declaration of Conduct with an awareness of the ISO26000 core subject framework.
In practicing our Sustainability Management, we review all of our corporate activities from the perspective of corporate social responsibility and work proactively to respond to social changes and demands. We have formulated the material issues to prioritize as we promote Sustainability Management and implement a range of initiatives focusing on these issues. We not only comply with all laws and regulations but also ensure that our corporate activities are carried out in accordance with the Declaration of Conduct. This website is also structured in accordance with the ISO26000 core subject framework.
Newsletter on Declaration of Conduct
Sumitomo Pharma provide training for all the officers and employees to enhance their understanding of the Declaration of Conduct. As an additional opportunity, we have been issuing a newsletter dedicated to this topic for the purpose of establishing and improving compliance and high ethics since fiscal 2014 and have been posting them periodically on our Intranet bulletin board.
The intranet site for Newsletter of Declaration of Conduct also allows employees to contribute by posting their experience and stories on initiatives at their workplace and exchange with one another their thoughts on compliance and corporate ethics.
Declaration of Conduct and ISO26000 Core Subjects
| The Declaration of Conduct | ISO26000 Core Subjects |
|---|---|
| 1. Follow through the slogan "Innovation today, healthier tomorrows." | Organizational Governance Human Rights Labour Practices The Environment Fair Operating Practices Consumer Issues Community Involvement and Development |
| 2. Pursue trustworthy corporate activities. | Organizational Governance Human Rights Fair Operating Practices Consumer Issues Community Involvement and Development |
| 3. Positively disclose information and properly manage information. | Organizational Governance Labour Practices The Environment Fair Operating Practices Consumer Issues |
| 4. Improve individual capabilities and collaborate with peers. | Organizational Governance Human Rights Labour Practices Community Involvement and Development |
| 5. Respect human rights. | Organizational Governance Human Rights Labour Practices |
| 6. Positively address global environmental issues. | Organizational Governance The Environment Community Involvement and Development |
| 7. Build harmonious relationships with society. | Organizational Governance The Environment Community Involvement and Development |
Sumitomo Pharma's Engagements in ISO26000 Core Subjects
| ISO26000 Core Subjects | Applicable item of the Declaration of Conduct | Sumitomo Pharma's Engagements | |
|---|---|---|---|
| Organizational Governance | Declaration of Conduct 1 Declaration of Conduct 2 Declaration of Conduct 3 Declaration of Conduct 4 Declaration of Conduct 5 Declaration of Conduct 6 Declaration of Conduct 7 |
●Implementation of Japan's Corporate Governance Code ●Optimizing the Management Structure, Audit System, and Internal Control Systems |
●Promoting Risk Management ●Compliance Implementation ●Appropriate Information Disclosure and Information Management |
| Human Rights | Declaration of Conduct 1 Declaration of Conduct 2 Declaration of Conduct 4 Declaration of Conduct 5 |
●Respect for Human Rights ●Eradicating All Forms of Discrimination ●Clinical Studies Put the Human Rights of Subjects First |
●Respect for Human Rights in Supply Chain Labor Conditions ●Initiatives to Prevent Harassment ●Building Good Relationship with the Workers Union |
| Labour Practices | Declaration of Conduct 1 Declaration of Conduct 3 Declaration of Conduct 4 Declaration of Conduct 5 |
●Promoting "Work Style Innovation" (improve usage rate of paid leave, prevent overwork, etc.) ●Promoting Diversity and Inclusion ●Supporting Active Participation by People with Disabilities through Appropriate Placement ●Creating an Environment in Which Employees Can Fully Exercise Their Abilities ●SMP Academy, a Training Program for Selected Employees, and Overseas Training with Open Recruitment |
●Promoting Dialogue between Management and Employees ●Our Efforts Against the Novel Coronavirus Disease (COVID-19) ●Working to Build Workplace Environments that Emphasize Employee Safety ●Implementing Health and Safety Risk Assessments ●Promoting Health Management and Supporting Mental Wellbeing ●Operating of Consultation Desks and Hotlines |
| The Environment | Declaration of Conduct 1 Declaration of Conduct 3 Declaration of Conduct 6 Declaration of Conduct 7 |
●Basic Environmental Policies ●Perspective on Environmental Impact ●Environmental Accounting ●Mid-term Environmental Goals ●Long-term Environmental Goals |
●Efforts to Save Energy and Reduce CO2 Emissions ●Effective Use of Resources ●Effective Use of Water Resources ●Initiatives on Biodiversity |
| Fair Operating Practices | Declaration of Conduct 1 Declaration of Conduct 2 Declaration of Conduct 3 |
●Respect for Intellectual Property ●Appropriate Information Disclosure and Information Management ●Ensuring Information Security ●Protecting and Managing Personal Information ●Preventing the Falsification and Leakage of Information |
●Corporate Activities Attaching Importance to Transparency ●Establish Proper Relationships with Medical Institutions and Patient Groups ●Fair Promotion Activities ●Implementing "Ethics in Procurement" as part of CSR Procurement |
| Consumer Issues | Declaration of Conduct 1 Declaration of Conduct 2 Declaration of Conduct 3 |
●Development of Innovative Products and Healthcare Solutions ●Efforts toward the United Nations' Sustainable Development Goals (SDGs) ●Initiatives to Improve Access to Medicines ●Initiatives to Ensure Safety of Pharmaceuticals |
●Encouragement of Proper Use of Pharmaceuticals ●Running a Medical Information Site, a Health Information Site, and a Product Information Center ●Ethical Considerations in Human Tissue Research, Animal Experimentation, and so on |
| Community Involvement and Development | Declaration of Conduct 1 Declaration of Conduct 2 Declaration of Conduct 4 Declaration of Conduct 6 Declaration of Conduct 7 |
●Development of Innovative Products and Healthcare Solutions ●Initiatives to Global Health ●Stakeholder Engagement ●Stakeholder Dialogue ●Basic Approach to Social Contribution Activities |
●Support through Employee Participation ●Support through Donations ●Social Supports ●Activities of Global Group Companies |